Previous Close | 2.4000 |
Open | 1.6600 |
Bid | 1.0000 |
Ask | 6.0000 |
Strike | 55.00 |
Expire Date | 2026-01-16 |
Day's Range | 2.4000 - 2.4000 |
Contract Range | N/A |
Volume | |
Open Interest | 16 |
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats